http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d07150d350af10d793f0f68f87dfc81
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | K. Price Price |
| name | Douglas K. Price Douglas K Price |
| given-name | Douglas K. Douglas Douglas K |
| organization-name | Genitourinary Malignancies Branch National Cancer Institute Bethesda Maryland USA 1Molecular Pharmacology Section; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Genitourinary Malignancies Branch, Center for Cancer Research National Cancer Institute Bethesda Maryland Molecular Pharmacology Program, National Cancer Institute, 9000 Rockville Pike, Building 10, Room 5A01, Bethesda, MD 20892, USA Molecular Pharmacology Section (C.T.K., C.E.B., S.B.O., D.K.P., W.D.F.), Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892; 2Molecular Pharmacology Section, Genitourinary Malignancies Branch, NCI, Bethesda, Maryland. From the Mid-West Center for Health Services Research and Development, Department of Veterans Affairs Medical Center; Chicago Veterans Affairs Healthcare System/Lakeside Division; Robert H. Lurie Comprehensive Cancer Center; and Division of Hematology/Oncology, Department of Medicine, and Division of Biostatistics, Department of Preventive Medicine, Northwestern University, Chicago, IL; Stanley Scott Cancer Center and Division of Hematology/Oncology, Louisiana State University School of Medicine, New... 4Molecular Pharmacology Section, Cancer Therapeutics Branch, National Cancer Institute, NIH, Bethesda, Maryland; Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland Molecular Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Molecular Pharmacology Section Genitourinary Malignancies Branch Center for Cancer Research National Cancer Institute NIH Bethesda MD USA 3Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA 1Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland; 2Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia; 3Department of Internal Medicine, University of Pisa, Pisa, Italy; 4Molecular Pharmacology Section and 5Biostatistics and Data Management Section, National Cancer Institute, Bethesda, Maryland a Molecular Pharmacology Section, National Cancer Institute, Bethesda, Maryland, USA 1Molecular Pharmacology Section, 2Medical Oncology Branch, and 1Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Clinical Pharmacology Research Core and Cancer Therapeutics Branch, National Cancer Institute, Bethesda, Maryland Molecular Pharmacology Section, National Cancer Institute, Bethesda, Maryland, USA. 1Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA 4Molecular Pharmacology Section, National Cancer Institute, Bethesda, Maryland; and Authors' Affiliations: 1Clinical Pharmacology Program, 2SAIC-Frederick, National Cancer Institute (NCI), Frederick; 3Medical Oncology Branch, Center for Cancer Research, NCI, Bethesda, Maryland; 4Laboratory of Respiratory Biology, National Institute of Environmental Health Science, Durham, North Carolina; 5Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; 6Biostatistics and Data Management Section, and 7Molecular Pharmacology Section, Center for Cancer Research, NCI; 8Cardiovascular Branch, National Heart Lung and Blood Institute, Bethesda, Maryland; and 9Quintiles Transnational Corporation, Research Triangle Park, North Carolina From the Medical Oncology Branch and the Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, and The Clinical Center, National Institutes of Health, Bethesda, MD; and the Mailman School of Public Health, Columbia University, New York, NY. Medical Pharmacology Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland Clinical Pharmacology Program, Office of the Clinical Director, and the Molecular Pharmacology Section, Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, MD, United States Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 2Molecular Pharmacology Section, |
Incoming Links
Total number of triples: 147.